Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Irritable Bowel Syndrome

  Free Subscription


Articles published in Scand J Gastroenterol

Retrieve available abstracts of 22 articles:
HTML format



Single Articles


    October 2022
  1. HONG G, Li Y, Yang M, Li G, et al
    Baseline gut microbial profiles are associated with the efficacy of Bacillus subtilis and Enterococcus faecium in IBS-D.
    Scand J Gastroenterol. 2022 Oct 25:1-10. doi: 10.1080/00365521.2022.2136013.
    PubMed     Abstract available


    August 2022
  2. YAN X, Wang J, Bai Y
    Potentials of circSOBP in the diagnosis and prognosis of gastric cancer.
    Scand J Gastroenterol. 2022 Aug 20:1-5. doi: 10.1080/00365521.2022.2088246.
    PubMed     Abstract available


    April 2022
  3. EL-SALHY M, Mazzawi T, Hausken T, Hatlebakk JG, et al
    The fecal microbiota transplantation response differs between patients with severe and moderate irritable bowel symptoms.
    Scand J Gastroenterol. 2022 Apr 29:1-10. doi: 10.1080/00365521.2022.2064725.
    PubMed     Abstract available


  4. HEDSTROM A, Kvarnstrom M, Lindberg G, Alsabeah S, et al
    High prevalence of gastrointestinal symptoms in patients with primary Sjogren's syndrome cannot be attributed to pancreatic exocrine insufficiency.
    Scand J Gastroenterol. 2022 Apr 24:1-7. doi: 10.1080/00365521.2022.2065888.
    PubMed     Abstract available


    March 2022
  5. WALLEN H, Ljotsson B, Svanborg C, Rydh S, et al
    Exposure based cognitive behavioral group therapy for IBS at a gastroenterological clinic - a clinical effectiveness study.
    Scand J Gastroenterol. 2022 Mar 9:1-8. doi: 10.1080/00365521.2022.2047220.
    PubMed     Abstract available


  6. TOUNY AA, Kenny E, Mansson M, Webb DL, et al
    Pain relief and pain intensity response to GLP-1 receptor agonist ROSE-010 in irritable bowel syndrome; clinical study cross-analysis with respect to patient characteristics.
    Scand J Gastroenterol. 2022 Mar 2:1-9. doi: 10.1080/00365521.2022.2041084.
    PubMed     Abstract available


    February 2022
  7. MAZZAWI T, Hausken T, El-Salhy M
    Changes in colonic enteroendocrine cells of patients with irritable bowel syndrome following fecal microbiota transplantation.
    Scand J Gastroenterol. 2022 Feb 14:1-5. doi: 10.1080/00365521.2022.2036809.
    PubMed     Abstract available


  8. JOHANSEN SG, Ness-Jensen E
    The changes in prevalence and risk of irritable bowel syndrome over time in a population-based cohort, the HUNT study, Norway.
    Scand J Gastroenterol. 2022 Feb 4:1-7. doi: 10.1080/00365521.2022.2028005.
    PubMed     Abstract available


  9. RUDERSTAM H, Ohlsson B
    Self-reported IBS and gastrointestinal symptoms in the general population are associated with asthma, drug consumption and a family history of gastrointestinal diseases.
    Scand J Gastroenterol. 2022 Feb 1:1-11. doi: 10.1080/00365521.2022.2031281.
    PubMed     Abstract available


    September 2021
  10. THOMAZ DE ALMEIDA CN, Tahan S, Areco KN, Morais MB, et al
    Association between abuse and neglect with functional constipation and irritable bowel syndrome in adolescents.
    Scand J Gastroenterol. 2021 Sep 1:1-6. doi: 10.1080/00365521.2021.1923059.
    PubMed     Abstract available


    May 2021
  11. VAN MEGEN F, Skodje GI, Stendahl M, Veierod MB, et al
    High disease burden in treated celiac patients - a web-based survey.
    Scand J Gastroenterol. 2021 May 30:1-7. doi: 10.1080/00365521.2021.1930146.
    PubMed     Abstract available


  12. MADSEN AMA, Halkjaer SI, Christensen AH, Gunther S, et al
    The effect of faecal microbiota transplantation on abdominal pain, stool frequency, and stool form in patients with moderate-to-severe irritable bowel syndrome: results from a randomised, double-blind, placebo-controlled study.
    Scand J Gastroenterol. 2021 May 17:1-9. doi: 10.1080/00365521.2021.1915375.
    PubMed     Abstract available


    February 2021
  13. MEIRA DE-FARIA F, Bednarska O, Strom M, Soderholm JD, et al
    Colonic paracellular permeability and circulating zonulin-related proteins.
    Scand J Gastroenterol. 2021 Feb 3:1-8. doi: 10.1080/00365521.2021.1879247.
    PubMed     Abstract available


    June 2020
  14. CHI Y, Li C, Wu LH, Wang HH, et al
    The relationship between dectin-1 and mast cells in patients with diarrhea-predominant irritable bowel syndrome.
    Scand J Gastroenterol. 2020 Jun 4:1-7. doi: 10.1080/00365521.2020.1774925.
    PubMed     Abstract available


    May 2020
  15. MOHAMMADIAN G, Dlugosz A, Shetye J, Lindberg G, et al
    Quantification of mucosal EEC in jejunum. A comparative study of IBS patients and healthy controls.
    Scand J Gastroenterol. 2020 May 22:1-6. doi: 10.1080/00365521.2020.1764615.
    PubMed     Abstract available


  16. KOTANI S, Fukuba N, Kawashima K, Mishima Y, et al
    Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Scand J Gastroenterol. 2020 May 15:1-5. doi: 10.1080/00365521.2020.1761998.
    PubMed     Abstract available


    April 2020
  17. BERG LK, Goll R, Fagerli E, Ludviksen JK, et al
    Intestinal inflammatory profile shows increase in a diversity of biomarkers in irritable bowel syndrome.
    Scand J Gastroenterol. 2020 Apr 24:1-6. doi: 10.1080/00365521.2020.1754455.
    PubMed     Abstract available


  18. VON VOLKMANN HL, Bronstad I, Tronstad RR, Dizdar V, et al
    Plasma levels of guanylins are reduced in patients with Crohn's disease.
    Scand J Gastroenterol. 2020 Apr 20:1-5. doi: 10.1080/00365521.2020.1748224.
    PubMed     Abstract available


    December 2019
  19. WANG B, Zhao W, Zhao C, Jin H, et al
    What impact do Rome IV criteria have on patients with IBS in China?
    Scand J Gastroenterol. 2019 Dec 12:1-8. doi: 10.1080/00365521.2019.1698650.
    PubMed     Abstract available


  20. HAMREFORS V, Fedorowski A, Ohlsson B
    Susceptibility to diarrhea is related to hemodynamic markers of sympathetic activation in the general population.
    Scand J Gastroenterol. 2019 Dec 2:1-7. doi: 10.1080/00365521.2019.1697742.
    PubMed     Abstract available


    November 2019
  21. WU KQ, Sun WJ, Li N, Chen YQ, et al
    Small intestinal bacterial overgrowth is associated with Diarrhea-predominant irritable bowel syndrome by increasing mainly Prevotella abundance.
    Scand J Gastroenterol. 2019 Nov 25:1-7. doi: 10.1080/00365521.2019.1694067.
    PubMed     Abstract available


  22. WILDER-SMITH CH, Drewes AM, Materna A, Olesen SS, et al
    Symptoms of mast cell activation syndrome in functional gastrointestinal disorders.
    Scand J Gastroenterol. 2019 Nov 5:1-4. doi: 10.1080/00365521.2019.1686059.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: